Clinic, Family & Community Collaboration to Treat Overweight and Obese Children (Stanford GOALS)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Stanford Goals is a large-scale, community-based randomized controlled trial of an innovative, interdisciplinary, multi-component, multi-level, multi-setting (MMM) approach to treating overweight and obese children. Primary Research Question: Will a 3-year, innovative, interdisciplinary, multi-component, multi-level, multi-setting (MMM) community-based intervention to treat overweight and obese children significantly reduce BMI compared to an enhanced standard care/health and nutrition education active comparison intervention?
| Condition | Intervention | Phase |
|---|---|---|
|
Obesity |
Behavioral: MMM Behavioral: Health and Nutrition Education |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Clinic, Family & Community Collaboration to Treat Overweight and Obese Children |
- body mass index trajectory (change) [ Time Frame: baseline, 1, 2 and 3 years ] [ Designated as safety issue: No ]
- physical activity measured by accelerometry [ Time Frame: baseline, 1, 2 and 3 years ] [ Designated as safety issue: No ]
- waist circumference [ Time Frame: baseline, 1, 2 and 3 years ] [ Designated as safety issue: No ]
- triceps skinfold thickness [ Time Frame: baseline, 1, 2 and 3 years ] [ Designated as safety issue: No ]
- resting blood pressure [ Time Frame: baseline, 1, 2 and 3 years ] [ Designated as safety issue: No ]
- resting heart rate [ Time Frame: baseline, 1, 2 and 3 years ] [ Designated as safety issue: No ]
- fasting Total Cholesterol, LDL-Cholesterol, HDL-Cholesterol, Triglycerides, Insulin, glucose, hemoglobin A1c, high sensitivity C-Reactive Protein, ALT [ Time Frame: baseline, 1, 2 and 3 years ] [ Designated as safety issue: No ]
- screen time and other sedentary behaviors [ Time Frame: baseline, 1, 2 and 3 years ] [ Designated as safety issue: No ]self-reported weekday, saturday and sunday, television, movies, video games, computer, portable media devices, mobile phones
- Average total daily energy intake [ Time Frame: baseline, 1, 2 and 3 years ] [ Designated as safety issue: No ]
- Waist-to-Height Ratio [ Time Frame: baseline, 1, 2 and 3 years ] [ Designated as safety issue: No ]
- Weight Concerns [ Time Frame: baseline, 1, 2 and 3 years ] [ Designated as safety issue: No ]
- Depressive symptoms [ Time Frame: baseline, 1, 2 and 3 years ] [ Designated as safety issue: No ]
- School performance [ Time Frame: baseline, 1, 2 and 3 years ] [ Designated as safety issue: No ]parent/guardian reported grades
- Children's sleep habits [ Time Frame: baseline, 1, 2 and 3 years ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 240 |
| Study Start Date: | July 2012 |
| Estimated Study Completion Date: | April 2017 |
| Estimated Primary Completion Date: | January 2017 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
Experimental: multi-component, multi-level, multi-setting (MMM)
|
Behavioral: MMM
|
|
Active Comparator: Health and Nutrition Education
Enhanced standard care/health and nutrition education intervention:
|
Behavioral: Health and Nutrition Education
Enhanced standard care/health and nutrition education intervention:
|
Detailed Description:
Single-blind study with all outcomes assessors (data collectors) and Investigators masked (blinded) to intervention assignment. Intention-to-treat analysis.
Eligibility| Ages Eligible for Study: | 7 Years to 11 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 7-11 years of age
- BMI greater than or equal to the 85th percentile for age and sex on the 2000 CDC BMI reference
Exclusion Criteria:
- Have been diagnosed with a medical condition affecting growth (a genetic or metabolic disease/syndrome associated with obesity, Type 1 diabetes, Type 2 diabetes taking medication, chronic gastrointestinal diseases, Chronic renal diseases, uncorrected structural heart disease, heart failure, heart transplant, anorexia nervosa or bulimia nervosa or binge eating disorder (present or past), AIDS or HIV infection, pregnancy);
- Take medications affecting growth (systemic corticosteroids more than 2 weeks in the past year, insulin, oral hypoglycemics, thyroid hormone, growth hormone);
- Have a condition limiting their participation in the interventions (e.g., unable to participate in routine physical education classes at school, requiring oxygen supplementation for exertion, developmental or physical disability preventing participation in interventions, children or parents/guardians who cannot medically participate in mild dietary restrictions and/or increased physical activity for any reason);
- Have a condition limiting participation in the assessments (child or primary caregiver not able to read surveys in English or Spanish, child two or more grade levels delayed in school for reading and writing in her native language);
- Are unable to read, understand or complete informed consent in English or Spanish;
- Plan to move from the San Francisco Bay Area within the next 36 months.
- Are deemed to have another characteristic that makes them unsuitable for participation in the study in the judgment of the Principal Investigator.
Contacts and Locations| Contact: Donna Matheson, PhD | (650) 724-5790 | donna.matheson@stanford.edu |
| United States, California | |
| Stanford University | Recruiting |
| Palo Alto, California, United States, 94304 | |
| Contact: Donna Matheson, PhD 650-724-5790 donna.matheson@stanford.edu | |
| Principal Investigator: Thomas N Robinson, MD, MPH | |
| Principal Investigator: | Thomas N Robinson, MD, MPH | Stanford University |
More Information
No publications provided
| Responsible Party: | Stanford University |
| ClinicalTrials.gov Identifier: | NCT01642836 History of Changes |
| Other Study ID Numbers: | spo47512, U01HL103629 |
| Study First Received: | July 10, 2012 |
| Last Updated: | July 16, 2012 |
| Health Authority: | United States: Data and Safety Monitoring Board United States: Institutional Review Board United States: Federal Government |
Additional relevant MeSH terms:
|
Obesity Overweight Overnutrition |
Nutrition Disorders Body Weight Signs and Symptoms |
ClinicalTrials.gov processed this record on May 23, 2013